Changes in company's own shares

Rhea-AI Summary

Alvotech (ALVO) filed a notification with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) on 29 Dec 2025 regarding changes in the company's own shares. An attachment titled Alvotech Own Shares Notification 29 Dec 2025 was submitted with the filing. Investors should review the attached notification for the specific details and scope of the share changes.

AI-generated analysis. How Rhea-AI works. Not financial advice.

News Market Reaction – ALVO

-5.51%

1 alert

-5.51% News Effect

-$96M Valuation Impact

$1.64B Market Cap

1.71K Volume

On the day this news was published, ALVO declined 5.51%, reflecting a notable negative market reaction. This price movement removed approximately $96M from the company's valuation, bringing the market cap to $1.64B at that time.

Data tracked by StockTitan Argus on the day of publication.

What This Means

The stock moved -5.5% in the session following this news. A negative reaction despite an administrat...

Analysis

The stock moved -5.5% in the session following this news. A negative reaction despite an administratively focused own-share CSSF filing could reflect broader concerns rather than this notice alone. Historically, Alvotech’s sharp declines clustered around financing and offering announcements, such as the mid‑December 2025 convertible bond launch. With shares already below the 200-day MA of $8.3 and far from the $13.7 52-week high, sentiment might remain sensitive to any signals about capital structure or governance changes.

Key Figures

CSSF filing date: 29 Dec 2025

1 metrics

CSSF filing date 29 Dec 2025 Own-share notification filing attachment date

Historical Context

5 past events · Latest: Dec 22 (Neutral)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Dec 22	Financial calendar	Neutral	+0.8%	Publication of 2026 financial calendar and key reporting dates.
Dec 22	Product launch	Positive	+0.8%	European launch of first-in-market Simponi biosimilar Gobivaz with Advanz.
Dec 19	Settlement/license deal	Positive	+3.6%	Settlement granting AVT06 U.S. marketing start in Q4 2026, if approved.
Dec 17	Convertible placement	Negative	-0.8%	USD 108M senior unsecured convertible bonds due 2030 in oversubscribed deal.
Dec 16	Convertible offering	Negative	-6.7%	Launch of USD 100M convertible bond plus 2025/2026 revenue and EBITDA guidance.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent news has generally moved ALVO in the same direction as the perceived news tone, with negative reactions around financing/offering announcements.

Recent Company History

Over recent months, Alvotech has reported multiple regulatory and financing milestones. In December 2025, it launched a Simponi biosimilar in Europe and secured a U.S. settlement for AVT06, both followed by positive price reactions. Convertible bond and offering announcements in mid‑December 2025 drew negative reactions, consistent with dilution concerns. Earlier 6-K filings through November 2025 highlighted EEA approvals and EMA review progress. Today’s CSSF own-share filing fits into an active period of capital and regulatory activity rather than a new strategic shift.

Regulatory & Risk Context

Short Interest: 2.55%

Short Interest

2.55% of shares outstanding

as of 2026-05-29 Days to cover: 6.95

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Attached is a filing with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding changes in company's own shares.

Attachment

• Alvotech Own Shares Notification 29 Dec 2025

FAQ

What did Alvotech (ALVO) announce in the CSSF filing on December 29, 2025?

Alvotech submitted a notification to the CSSF reporting changes in the company's own shares with an attachment named Alvotech Own Shares Notification 29 Dec 2025.

Where was Alvotech's (ALVO) own shares notification filed on December 29, 2025?

The notification was filed with the Luxembourg regulator, the Commission de Surveillance du Secteur Financier (CSSF).

How can investors see the details of Alvotech's (ALVO) own shares change on December 29, 2025?

Investors should review the attached document titled Alvotech Own Shares Notification 29 Dec 2025 included with the CSSF filing for the specific details.

Does the December 29, 2025 CSSF filing for Alvotech (ALVO) state the number or value of shares changed?

The brief notice identifies a filing about changes in own shares but does not specify numbers or values; those details would be in the attached notification.

What immediate investor actions are suggested after Alvotech's (ALVO) own shares notification on December 29, 2025?

Review the attached notification for specifics, monitor company filings and investor relations, and consider contacting investor relations for clarification.